Fundraising Fox

Nicoya

7 known investors

nicoyalife.com ↗

Nicoya develops instruments and platforms for protein interaction and dynamics analysis, including SPR (Revo, OpenSPR, Alto), millisecond HDX-MS (FastHDX), and circular dichroism systems for measuring binding, kinetics, structure, and stability. Its tools serve academic and biopharma scientists studying structural biology and biologics.

BiotechDeep TechHardware

Investors · 7

Garage CapitalWaterloo
Graphite VenturesToronto · $500K – $1.5M
Innovative Solutions CanadaOttawa · $2M
Whitecap Venture PartnersToronto · $1.5M – $3.6M
Angel OnereportedKyiv · $50K – $200K
Maple Leaf AngelsreportedToronto
Ripple VenturesreportedToronto · $250K – $1M

In the news

Splendid Spoon Raises $12 Million in Series B Funding Led by Nicoyaprnewswire.com · Feb 2022Nicoya receives over $290K in funding to develop a portable COVID-19 diagnostic testnicoyalife.com · Jun 2020Nicoya raises $10 million CAD to aid drug treatment development | BetaKitbetakit.com · Jan 2020Nicoya Raises $10 Million in Series A Funding to Make Drug Discovery Digitalnicoyalife.com · Jan 2020Nicoya Lifesciences Raises $2 million to Change how the Next Generation of Drugs will be Discoveredprweb.com · Jan 2018Nicoya Lifesciences Funding Round | Seedtableseedtable.com

Frequently asked questions

What does Nicoya do?
Nicoya develops instruments and platforms for protein interaction and dynamics analysis, including SPR (Revo, OpenSPR, Alto), millisecond HDX-MS (FastHDX), and circular dichroism systems for measuring binding, kinetics, structure, and stability. Its tools serve academic and biopharma scientists studying structural biology and biologics.
Who are Nicoya's investors?
Nicoya's investors include Garage Capital, Graphite Ventures, Innovative Solutions Canada, Whitecap Venture Partners, Angel One, Maple Leaf Angels, Ripple Ventures.